Online citations, reference lists, and bibliographies.

N‐terminal Pro‐brain Natriuretic Peptide In The Elderly With Myocardial Infarction

I. Szadkowska, J. Goch, Janusz Kawiński, K. Chiżyński
Published 2008 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
The myocardial infarction (MI) results in the change of the levels of N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) in blood. In addition, attention is paid to the dependence of NT‐proBNP levels on the patients' age. However, the behavior of natriuretic peptide levels has not been recognized well enough in the elderly with MI treated with invasive methods.
This paper references
10.1161/hc0502.103010
Utility of B-Natriuretic Peptide in Detecting Diastolic Dysfunction
E. Lubien (2002)
10.1161/01.CIR.0000134480.06723.D8
N-Terminal Pro-Brain Natriuretic Peptide on Admission Has Prognostic Value Across the Whole Spectrum of Acute Coronary Syndromes
M. Galvani (2004)
10.1016/S0002-8703(98)70338-2
Plasma brain natriuretic peptide is a biochemical marker for the prediction of progressive ventricular remodeling after acute myocardial infarction.
N. Nagaya (1998)
10.1161/01.CIR.0000070953.76250.B9
B-Type Natriuretic Peptides and Ejection Fraction for Prognosis After Myocardial Infarction
A. Richards (2003)
10.1161/01.CIR.93.11.1963
Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide.
T. Omland (1996)
10.1016/S1388-9842(00)00121-5
In‐hospital heart failure, first‐year ventricular dilatation and 10‐year survival after acute myocardial infarction
N. Gadsbøll (2001)
10.1016/S1062-1458(02)00720-1
Utility of B-Natriuretic Peptide in Detecting Diastolic Dysfunction: Comparison With Doppler Velocity Recordings
E. Lubien (2002)
10.1007/s00392-008-0697-y
Perkutane Koronarinterventionen (PCI)
T. Bonzel (2008)
10.1515/CCLM.2004.265
Concentrations of N-terminal pro-brain natriuretic peptide and troponin T in plasma of 75-year-old apparently healthy persons
K. Huber (2004)
10.1016/J.EUJE.2005.12.014
Recommendations for chamber quantification.
R. Lang (2006)
10.1016/J.AHJ.2004.01.013
Impact of age, race, and sex on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: results from the Breathing Not Properly (BNP) multinational study
A. Maisel (2004)
10.1016/J.AMJCARD.2004.01.008
Comparison of B-type natriuretic peptide levels in patients with heart failure with versus without mitral regurgitation.
S. A. Mayer (2004)
10.1056/NEJMOA011053
The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes.
J. D. de Lemos (2001)
10.1161/01.HYP.0000170140.36633.8f
Effect of Compensated Renal Dysfunction on Approved Heart Failure Markers: Direct Comparison of Brain Natriuretic Peptide (BNP) and N-Terminal Pro-BNP
A. Luchner (2005)
10.1093/EURHEARTJ/EHI138
Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology.
S. Silber (2005)
10.1136/hrt.81.2.114
Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction
A. Richards (1999)
10.1053/EUHJ.1999.2045
Profile of plasma N-terminal proBNP following acute myocardial infarction; correlation with left ventricular systolic dysfunction.
S. Talwar (2000)
10.1016/S0735-1097(03)00168-2
Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18.
D. Morrow (2003)
10.1093/EURHEARTJ/EHI204
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.
K. Swedberg (2005)
10.1016/J.CCCN.2005.05.021
Influence of renal function on N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients admitted for dyspnoea in the Emergency Department: comparison with brain natriuretic peptide (BNP).
C. Chenevier-Gobeaux (2005)
10.1067/MHJ.2002.122168
Detection of left ventricular enlargement and impaired systolic function with plasma N-terminal pro brain natriuretic peptide concentrations.
B. Groenning (2002)
10.1056/NEJMOA031681
Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea.
C. Mueller (2004)
10.1016/J.AMJCARD.2004.12.032
The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study.
J. Januzzi (2005)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar